MedTrace Logo

Phase 1 Food Effect Study for Alicaforsen Tablets

NCT03473626 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2018-11-07

No results posted yet for this study

Summary

Phase 1 study to compare the effect of food on alicaforsen tablet.

Conditions

Interventions

DRUG

Alicaforsen

Alicaforsen tablet

Sponsors & Collaborators

  • Atlantic Pharmaceuticals Ltd

    lead INDUSTRY

Principal Investigators

  • Chris Dunk · Atlantic Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-16
Primary Completion
2018-04-06
Completion
2018-04-06

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03473626 on ClinicalTrials.gov